Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 years of age or older~2. Patients undergoing upper endoscopic ultrasound~3. American Society of Anesthesiology (ASA) Physical Status I-III~4. BMI ≥35 kg/m2 or documented Obstructive Sleep Apnea~5. Has provided written informed consent~Exclusion Criteria:~1. Inpatient status~2. Active Congestive Heart Failure Exacerbation~3. Untreated ischemic heart disease~4. Acute exacerbation of respiratory disorders, including COPD and asthma~5. Emergent procedures~6. Pregnancy~7. Previous enrollment in this study~8. Inability to provide informed consent~9. Additional medical testing planned for the same day~10. History of allergic reaction to Propofol~11. Tracheostomy~12. Supra-glottic or sub-glottic tumor~13. Gastrointestinal tract obstruction or delayed transit (including delayed gastric emptying, gastric bezoar, achalasia, toxic megacolon).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Facial mask (Type: ACTIVE_COMPARATOR): facial mask for oxygen delivery
- SuperNO2VA (Type: EXPERIMENTAL): SuperNO2VA is CPAP device to deliver oxygen with nasal mask rather than with facial mask

Based on this trial design, predict the completion outcome and termination type (if applicable).